[HTML][HTML] Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
S Stacchiotti, A Gronchi, P Fossati, T Akiyama… - Annals of …, 2017 - Elsevier
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until
recently, there was no consensus among experts regarding appropriate clinical …
recently, there was no consensus among experts regarding appropriate clinical …
Chordoma—current understanding and modern treatment paradigms
Chordoma is a low-grade notochordal tumor of the skull base, mobile spine and sacrum
which behaves malignantly and confers a poor prognosis despite indolent growth patterns …
which behaves malignantly and confers a poor prognosis despite indolent growth patterns …
[PDF][PDF] Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Highlights•This Clinical Practice Guideline provides key recommendations on the
management of bone sarcomas.•Recommendations have been agreed following a …
management of bone sarcomas.•Recommendations have been agreed following a …
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, S Bielack, N Abecassis, HT Aro… - Annals of …, 2018 - annalsofoncology.org
Primary bone tumours are rare, accounting for< 0.2% of malignant neoplasms registered in
the EUROCARE (European Cancer Registry based study on survival and care of cancer …
the EUROCARE (European Cancer Registry based study on survival and care of cancer …
[PDF][PDF] Ary
R JÚNIOR - Entrevista: Prof. Dr. Ary Rocco Junior [set. 2015] …, 2015 - scholar.archive.org
Supplementary Table S1. Search Terms Page 1 1 Supplementary Table S1. Search Terms
Pubmed: 442 results ("Chordoma"[Mesh] OR "chordoma"[tw] OR "chordomas"[tw] OR "chorda"[tw] …
Pubmed: 442 results ("Chordoma"[Mesh] OR "chordoma"[tw] OR "chordomas"[tw] OR "chorda"[tw] …
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials
A Schuck, S Ahrens, M Paulussen, M Kuhlen… - International Journal of …, 2003 - Elsevier
Purpose: The impact of different local therapy approaches on local control, event-free
survival, and secondary malignancies in the CESS 81, CESS 86, and EICESS 92 trials was …
survival, and secondary malignancies in the CESS 81, CESS 86, and EICESS 92 trials was …
Carbon ion radiation therapy for unresectable sacral chordoma: an analysis of 188 cases
R Imai, T Kamada, N Araki, S Abe, Y Iwamoto… - International Journal of …, 2016 - Elsevier
Purpose To evaluate the results of carbon ion radiation therapy administered to 188 patients
with unresectable primary sacral chordomas. Patients and Methods One hundred eighty …
with unresectable primary sacral chordomas. Patients and Methods One hundred eighty …
[HTML][HTML] Clinicopathologic characteristics of poorly differentiated chordoma
Chordoma is a rare malignant tumor of bone with high morbidity and mortality. Recently,
aggressive pediatric poorly differentiated chordoma with SMARCB1 loss has been …
aggressive pediatric poorly differentiated chordoma with SMARCB1 loss has been …
High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors
RL Rotondo, W Folkert, NJ Liebsch, YLE Chen… - … of Neurosurgery: Spine, 2015 - thejns.org
OBJECT Spinal chordomas can have high local recurrence rates after surgery with or
without conventional dose radiation therapy (RT). Treatment outcomes and prognostic …
without conventional dose radiation therapy (RT). Treatment outcomes and prognostic …
Chondrosarcoma-from molecular pathology to novel therapies
Simple Summary Chondrosarcoma (CHS) belongs to a broad group of sarcomas and is the
second most frequent malignant bone tumor. Due to its resistance to chemo-and …
second most frequent malignant bone tumor. Due to its resistance to chemo-and …